← All diseases
Cancer
Esophageal cancer
Do you want to be notified when there is new research about Esophageal Cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Esophageal Cancer is available. View what Premium costs.
Publications and studies (2589)
- Combined assessment of muscle quality and quantity predicts oncological outcome in patients with esophageal cancer. (2023/06/01) ♡
- Predicting long-term survival and time-to-recurrence after esophagectomy in patients with esophageal cancer - Development and validation of a multivariate prediction model. (2023/06/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy of Aidi injection combined with chemotherapy, radiotherapy or chemoradiotherapy for unresectable esophageal cancer treatment: A meta-analysis and systematic review of 29 randomized controlled trials based on Asian populations (China). (2023/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of aero-digestive fistulas: the gastroenterologist's perspective, a narrative review. (2023/05/16) ♡
- High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed. (2023/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Nutritional supportive care in the course of patients with esophagogastric cancers]. (2023/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Interventional gastroenterology in oncology. (2023/05/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. ASO Author Reflections: Significance of Esophageal Cancerous Stenosis: The Nutritional, Survival, and Oncological Impacts. (2023/05/01) ♡
- Is Thoracic Duct Resection Necessary for Esophageal Squamous Cell Carcinoma Patients Treated with Neoadjuvant Chemoradiotherapy? A Propensity-Matched Analysis Based on the Comprehensive Registry of Esophageal Cancer in Japan. (2023/05/01) ♡
- Wide Variability in Dysplasia Detection Rate and Adherence to Seattle Protocol and Surveillance Recommendations in Barrett's Esophagus: A Population-Based Analysis Using the GiQuic National Quality Benchmarking Registry. (2023/05/01) ♡
- Impact of Body Mass Index on Major Complications, Multiple Complications, In-hospital Mortality, and Failure to Rescue After Esophagectomy for Esophageal Cancer: A Nationwide Inpatient Database Study in Japan. (2023/04/01) ♡
- Trends in Distal Esophageal and Gastroesophageal Junction Cancer Care: The Dutch Nationwide Ivory Study. (2023/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer From a Real-World Multicenter Study. (2023/04/01) ♡
- Patient Knowledge, Risk Perception, and Barriers to Barrett's Esophagus Screening. (2023/04/01) ♡
- The prognostic significance of preoperative nutritional/inflammatory markers and clinicopathological features in resectable esophagectomy patients: possibility of nutritional intervention. (2023/04/01) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50). (2023/04/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial. (2023/04/01) ♡
- Why Has Screening and Surveillance for Barrett's Esophageal Fallen Short in Voting the Rising Incidence of Esophageal Adenocarcinoma? (2023/04/01) ♡
- Circ_0058063 regulates the development of esophageal cancer through miR-377-3p/HOXA1 axis. (2023/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Intra-oral acupuncture treatment for chronic aspiration after esophageal cancer surgery: a case report. (2023/04/01) ♡
- Risk Factors for Esophagojejunal Anastomotic Leakage in Gastric Cancer Patients after Total Gastrectomy. (2023/03/11) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Effect of Oral Nutritional Supplements on Patients with Esophageal Cancer During Radiotherapy (2023/03/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Commentary: Are we at a CrossRoads in neoadjuvant therapy for esophageal cancer? (2023/03/01) ♡
- Esophagectomy Complications Impact Long-term Survival: A National Cancer Database Analysis. (2023/03/01) ♡
- Spinal cord compression related to an esophageal self-expandable metal stent. (2023/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment of portal hypertension in patients with HCC in the era of Baveno VII. (2023/03/01) ♡
- Nomogram model for predicting esophagogastric varices in hepatocellular carcinoma with cirrhosis. (2023/03/01) ♡
- Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery. (2023/03/01) ♡
- Chemoradiotherapy with paclitaxel liposome plus cisplatin for locally advanced esophageal squamous cell carcinoma: A retrospective analysis. (2023/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Network Pharmacology and in vitro Experimental Verification on Intervention of Quercetin, Present in Chinese Medicine Yishen Qutong Granules, on Esophageal Cancer. (2023/03/01) ♡
- Liujunzi decoction exerts potent antitumor activity in oesophageal squamous cell carcinoma by inhibiting miR-34a/STAT3/IL-6r feedback loop, and modifies antitumor immunity. (2023/03/01) ♡
- Long-term effect of hospital volume on the postoperative prognosis of 158,618 patients with esophageal squamous cell carcinoma in China. (2023/02/16) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Morning chronotype and digestive tract cancers: Mendelian randomization study. (2023/02/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Huanglian Jiedu plaster ameliorated X-ray induced radiation dermatitis injury by inhibiting HMGB1-mediated macrophage-inflammatory interaction. (2023/02/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gastrointestinal disorders and intestinal bacteria: Advances in research and applications in therapy. (2023/02/07) ♡
- ARID2 mitigates hepatic steatosis by promoting the ubiquitination of JAK2. (2023/02/01) ♡
- Screening and management of portal hypertension in advanced hepatocellular carcinoma: A French practice survey. (2023/02/01) ♡
- Systematic study of tissue factor expression in solid tumors. (2023/02/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Home-based physical activity after treatment for esophageal cancer-A randomized controlled trial. (2023/02/01) ♡
- PafR/stat3 axis maintains the symbiotic ecosystem between tumor and stroma to facilitate tumor malignancy. (2023/02/01) ♡
- The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma. (2023/01/19) ♡
- Comparative genomic analysis of esophageal squamous cell carcinoma among different geographic regions. (2023/01/18) ♡
- Efficacy of modified thoraco-laparoscopic Ivor-Lewis versus traditional thoraco-laparoscopic Ivor-Lewis for esophageal cancer: Propensity score-matched analysis. (2023/01/17) ♡
- A population-based investigation: How to identify high-risk T1-2N0 esophageal cancer patients? (2023/01/17) ♡
- Concomitant preoperative airflow obstruction confers worse prognosis after trans-thoracic surgery for esophageal cancer. (2023/01/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Immune checkpoint inhibitor-related vitiligo-like depigmentation in non-melanoma advanced cancer: A report of three cases and a pooled analysis of individual patient data. (2023/01/13) ♡
- Predictive models for the risk and prognosis of bone metastasis in patients with newly-diagnosed esophageal cancer: A retrospective cohort study. (2023/01/13) ♡
- Treatment mode and prognosis of esophageal perforation after radiotherapy in patients with esophageal carcinoma. (2023/01/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The evolving role of radiation in pancreatic cancer. (2023/01/11) ♡
- Clinical outcomes of salvage radiotherapy in patients with supraclavicular lymph node metastases after esophagectomy (2023/01/11) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.